SCHEMBL1487489

SCHEMBL1487489

CCCCCCCCCCCC(=O)OC(C)CCCC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.69
MAPT P10636 3/20 0.59
MAPK1 P28482 2/20 0.59
FAAH O00519 5/20 0.58
CNR1 P21554 1/20 0.58
CNR2 P34972 1/20 0.58
ALDH1A1 P00352 1/20 0.56
EPHX2 P34913 1/20 0.53
DGKA P23743 1/20 0.52
PRKCA P17252 1/20 0.51
PRKCE Q02156 1/20 0.51
PRKCQ Q04759 1/20 0.51
PRKCD Q05655 1/20 0.51
MEN1 O00255 1/20 0.47
GMNN O75496 1/20 0.47
HSP90AA1 P07900 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NR1H4 Q96RI1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1970714 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL18188008 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL26740661 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL27475552 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL4390947 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL27991387 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL28218064 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL5968215 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL27991394 1.00 LMNA (0.69) LMNAMAPTMAPK1FAAHCNR1
SCHEMBL29606986 0.98 LMNA (0.67) LMNAMAPTMAPK1FAAHCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101668510-A ester of hexyldecanol having short-chained fatty acids COGNIS IP MAN GMBH 2010-03-10 CN claimed
US-20250206864-A1 POLYMER AND COMPOSITION FUJIFILM CORPORATION (JP) 2025-06-26 US disclosed
CN-119947695-A Growth factor formulations 塔普克斯制药公司 2025-05-06 CN disclosed
CN-119894949-A Polymer, composition 富士胶片株式会社 2025-04-25 CN disclosed
CN-113873996-B Personal care compositions and malodor control methods 株式会社资生堂 2025-02-18 CN disclosed
CN-118829433-A Respiratory stimulant parenteral formulations 依那拉治疗股份有限公司 2024-10-22 CN disclosed
CN-112074736-B UV filter composition, method for the production thereof and use thereof 巴斯夫欧洲公司 2024-10-01 CN disclosed
CN-118488840-A Methods of treating respiratory depression modulated by non-opioid agents 依那拉治疗股份有限公司 2024-08-13 CN disclosed
WO-2024070463-A1 POLYMER AND COMPOSITION 富士フイルム株式会社 2024-04-04 WO disclosed
CN-117529306-A Nicotinamide Adenine Dinucleotide (NAD) compositions, methods of making and methods of using the same 索维达解决方案有限公司 2024-02-06 CN disclosed
WO-2007009879-A1 PRESERVATIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-01-25 WO disclosed
US-20050255055-A1 Merocyanine derivatives for cosmetic use CIBA SPECIALTY CHEMICALS CORP. 2005-11-17 US disclosed
CN-1212792-C Appliance with ball for applying liquid composition OREAL (FR) 2005-08-03 CN disclosed
CN-1642522-A Uv absorber compositions comprising a hydroxyphenyltriazine compound CIBA SC HOLDING AG (CH) 2005-07-20 CN disclosed
EP-1549283-A1 MEROCYANINE DERIVATIVES FOR COSMETIC USE Ciba SC Holding AG (CH) 2005-07-06 EP disclosed
US-20050129632-A1 Uv absorber compositions comprising a hydroxyphenyltriazine compound CIBA SPECIALTY CHEMICALS CORP. 2005-06-16 US disclosed
EP-1482904-A1 UV ABSORBER COMPOSITIONS COMPRISING A HYDROXYPHENYLTRIAZINE COMPOUND Ciba SC Holding AG (CH) 2004-12-08 EP disclosed
WO-2004006878-A1 MEROCYANINE DERIVATIVES FOR COSMETIC USE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-01-22 WO disclosed
WO-2003075875-A1 UV ABSORBER COMPOSITIONS COMPRISING A HYDROXYPHENYLTRIAZINE COMPOUND CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-09-18 WO disclosed
CN-1336151-A Appliance with ball for applying liquid composition OREAL (FR) 2002-02-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050129632-A1 Uv absorber compositions comprising a hydroxyphenyltriazine compound C1R, C5, C3AR1 LMNA 1949/4885MAPT 3054/4885MAPK1 4448/4885
US-20250206864-A1 POLYMER AND COMPOSITION CCNA1, ERCC1, RAD51 LMNA 206/4885MAPT 372/4885MAPK1 1200/4885
US-20050255055-A1 Merocyanine derivatives for cosmetic use C5, MSH6, C1R LMNA 2948/4885MAPT 3956/4885MAPK1 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.